Which Conditions Are on the Compassionate Allowances List?
Compassionate Allowances is Social Security’s fast track for disability claims involving conditions so severe that they clearly meet its definition of disability, mostly aggressive cancers, adult brain disorders such as ALS, and rare disorders that affect children. The list has 314 conditions after 14 were added on August 11, 2026, and Social Security says more than 1.2 million people have been approved through it.
It is not a separate benefit and not an automatic approval. A claim flagged as a compassionate allowance is decided by the same rules for SSDI or SSI, with the same work credit, income and evidence requirements, and the usual five-month waiting period before SSDI payments start. What changes is speed: the claim is identified early and handled by specially trained examiners as an expedited case.
Search tool
Compassionate Allowances Conditions
All 314 conditions on Social Security’s list, updated August 2026. Search by any name, including other names for the same condition.
Each condition links to Social Security’s official summary, which lists other names, how it is diagnosed and the medical evidence examiners look for.
- 1p36 Deletion SyndromeSSA summary ↗
- Acute LeukemiaSSA summary ↗
- Adenylosuccinate Lyase Deficiency – Neonatal Form and Type 1New August 2026SSA summary ↗
- Adrenal Cancer – with Distant Metastases or Inoperable, Unresectable or RecurrentSSA summary ↗
- Adult Heart Transplant Wait List – Status Levels 1-4SSA summary ↗
- Adult Non-Hodgkin LymphomaSSA summary ↗
- Adult-Onset Huntington DiseaseSSA summary ↗
- Aicardi SyndromeNew August 2026SSA summary ↗
- Aicardi-Goutieres SyndromeSSA summary ↗
- Alexander Disease (ALX) – Neonatal and InfantileSSA summary ↗
- Allan-Herndon-Dudley SyndromeSSA summary ↗
- Alobar HoloprosencephalySSA summary ↗
- Alpers DiseaseSSA summary ↗
- Alpha Mannosidosis – Type II and IIISSA summary ↗
- ALS/Parkinsonism Dementia ComplexSSA summary ↗
- Alstrom SyndromeSSA summary ↗
- Alveolar Soft Part SarcomaSSA summary ↗
- Amegakaryocytic ThrombocytopeniaSSA summary ↗
- Amyotrophic Lateral Sclerosis (ALS)SSA summary ↗
- Anaplastic Adrenal Cancer – Adult with Distant Metastases or Inoperable, Unresectable or RecurrentSSA summary ↗
- Anaplastic EpendymomaSSA summary ↗
- Angelman SyndromeSSA summary ↗
- Angioimmunoblastic T-Cell LymphomaSSA summary ↗
- AngiosarcomaSSA summary ↗
- Aortic AtresiaSSA summary ↗
- Aplastic AnemiaSSA summary ↗
- Astrocytoma – Grade III and IVSSA summary ↗
- Ataxia TelangiectasiaSSA summary ↗
- Atypical Teratoid/Rhabdoid TumorSSA summary ↗
- Au-Kline SyndromeSSA summary ↗
- Bainbridge-Ropers SyndromeSSA summary ↗
- Baraitser-Winter SyndromeNew August 2026SSA summary ↗
- Batten DiseaseSSA summary ↗
- Beare-Stevenson Cutis Gyrata SyndromeNew August 2026SSA summary ↗
- Beta Thalassemia MajorSSA summary ↗
- Bilateral AnophthalmiaSSA summary ↗
- Bilateral Optic Atrophy- InfantileSSA summary ↗
- Bilateral RetinoblastomaSSA summary ↗
- Bladder Cancer – with Distant Metastases or Inoperable or UnresectableSSA summary ↗
- Blastic Plasmacytoid Dendritic Cell NeoplasmSSA summary ↗
- Bohring-Opitz SyndromeNew August 2026SSA summary ↗
- Breast Cancer – with Distant Metastases or Inoperable or UnresectableSSA summary ↗
- CACH – Vanishing White Matter Disease – Congenital, Infantile and Early Childhood Onset FormsSSA summary ↗
- CalciphylaxisSSA summary ↗
- Canavan Disease (CD)SSA summary ↗
- Carcinoma of Unknown Primary SiteSSA summary ↗
- Cardiac Amyloidosis- AL TypeSSA summary ↗
- Carey-Fineman-Ziter SyndromeSSA summary ↗
- CASK-Related Gene DisordersNew August 2026SSA summary ↗
- Caudal Regression Syndrome – Types III and IVSSA summary ↗
- CDKL5 Deficiency DisorderSSA summary ↗
- Cerebro Oculo Facio Skeletal (COFS) SyndromeSSA summary ↗
- Cerebrotendinous XanthomatosisSSA summary ↗
- Charlevoix-Saguenay Spastic AtaxiaSSA summary ↗
- Child Heart Transplant Wait List – Status Levels 1A/1BSSA summary ↗
- Child Lymphoblastic LymphomaSSA summary ↗
- Child LymphomaSSA summary ↗
- Child Neuroblastoma – with Distant Metastases or RecurrentSSA summary ↗
- CholangiocarcinomaSSA summary ↗
- Chondrosarcoma – with Multimodal TherapySSA summary ↗
- Choroid Plexus CarcinomaSSA summary ↗
- Chronic Idiopathic Intestinal Pseudo ObstructionSSA summary ↗
- Chronic Myelogenous Leukemia (CML) – Blast PhaseSSA summary ↗
- CIC-Rearranged SarcomaSSA summary ↗
- Coffin-Lowry SyndromeSSA summary ↗
- Congenital LymphedemaSSA summary ↗
- Congenital Myotonic DystrophySSA summary ↗
- Congenital Zika SyndromeSSA summary ↗
- Cornelia de Lange Syndrome – Classic FormSSA summary ↗
- Corticobasal DegenerationSSA summary ↗
- Costello SyndromeSSA summary ↗
- Creutzfeldt-Jakob Disease (CJD) – AdultSSA summary ↗
- Cri du Chat SyndromeSSA summary ↗
- Degos Disease – SystemicSSA summary ↗
- DeSanctis Cacchione SyndromeSSA summary ↗
- Desmoplastic MesotheliomaSSA summary ↗
- Desmoplastic Small Round Cell TumorsSSA summary ↗
- Dravet SyndromeSSA summary ↗
- Duchenne Muscular Dystrophy – AdultSSA summary ↗
- Edwards Syndrome (Trisomy 18)SSA summary ↗
- Eisenmenger SyndromeSSA summary ↗
- Endometrial Stromal SarcomaSSA summary ↗
- Endomyocardial FibrosisSSA summary ↗
- Ependymoblastoma (Child Brain Cancer)SSA summary ↗
- Erdheim Chester DiseaseSSA summary ↗
- Esophageal CancerSSA summary ↗
- EsthesioneuroblastomaSSA summary ↗
- Ewing SarcomaSSA summary ↗
- Farber's Disease (FD) – InfantileSSA summary ↗
- Fatal Familial InsomniaSSA summary ↗
- Fibrodysplasia Ossificans ProgressivaSSA summary ↗
- Fibrolamellar CancerSSA summary ↗
- Follicular Dendritic Cell Sarcoma – Metastatic or RecurrentSSA summary ↗
- FOXG1 SyndromeSSA summary ↗
- Friedreich's Ataxia (FRDA)SSA summary ↗
- Frontotemporal Dementia (FTD), Pick's Disease -Type A – AdultSSA summary ↗
- Fryns SyndromeSSA summary ↗
- Fucosidosis – Type 1SSA summary ↗
- Fukuyama Congenital Muscular DystrophySSA summary ↗
- Fulminant Giant Cell MyocarditisSSA summary ↗
- Galactosialidosis – Early and Late Infantile TypesSSA summary ↗
- Gallbladder CancerSSA summary ↗
- Gaucher Disease (GD) – Type 2SSA summary ↗
- Gerstmann-Straussler-Scheinker DiseaseSSA summary ↗
- Giant Axonal NeuropathySSA summary ↗
- Glioblastoma Multiforme (Brain Cancer)SSA summary ↗
- Glioma – Grade III and IVSSA summary ↗
- Glutaric Acidemia – Type IISSA summary ↗
- GM1 Gangliosidosis – Infantile and Juvenile FormsSSA summary ↗
- Harlequin Ichthyosis – ChildSSA summary ↗
- Head and Neck Cancers – with Distant Metastasis or Inoperable or UnresectableSSA summary ↗
- Heart Transplant Graft FailureSSA summary ↗
- Hematopoietic Stem Cell TransplantationSSA summary ↗
- Hemophagocytic Lymphohistiocytosis (HLH) – Familial TypeSSA summary ↗
- HepatoblastomaSSA summary ↗
- Hepatocellular CarcinomaSSA summary ↗
- Hepatopulmonary SyndromeSSA summary ↗
- Hepatorenal SyndromeSSA summary ↗
- Hepatosplenic T-Cell LymphomaNew August 2026SSA summary ↗
- Histiocytic MalignanciesSSA summary ↗
- Histiocytosis SyndromesSSA summary ↗
- Hoyeraal-Hreidarsson SyndromeSSA summary ↗
- Hutchinson-Gilford Progeria SyndromeSSA summary ↗
- HydranencephalySSA summary ↗
- Hypocomplementemic Urticarial Vasculitis SyndromeSSA summary ↗
- Hypophosphatasia Perinatal (Lethal) and Infantile Onset TypesSSA summary ↗
- Hypoplastic Left Heart SyndromeSSA summary ↗
- I Cell DiseaseSSA summary ↗
- Idiopathic Pulmonary FibrosisSSA summary ↗
- Infantile Free Sialic Acid Storage DiseaseSSA summary ↗
- Infantile Neuroaxonal Dystrophy (INAD)SSA summary ↗
- Infantile Neuronal Ceroid LipofuscinosesSSA summary ↗
- Inflammatory Breast Cancer (IBC)SSA summary ↗
- Intracranial HemangiopericytomaSSA summary ↗
- Jervell and Lange-Nielsen SyndromeSSA summary ↗
- Joubert SyndromeSSA summary ↗
- Junctional Epidermolysis Bullosa – Lethal TypeSSA summary ↗
- Juvenile Onset Huntington DiseaseSSA summary ↗
- Kidney Cancer – Inoperable or UnresectableSSA summary ↗
- Kleefstra SyndromeSSA summary ↗
- Krabbe Disease (KD) – InfantileSSA summary ↗
- Kufs Disease – Type A and BSSA summary ↗
- Lafora DiseaseNew August 2026SSA summary ↗
- Large Intestine Cancer – with Distant Metastasis or Inoperable, Unresectable or RecurrentSSA summary ↗
- Late Infantile Neuronal Ceroid LipofuscinosesSSA summary ↗
- Leber Congenital AmaurosisSSA summary ↗
- Leigh’s DiseaseSSA summary ↗
- LeiomyosarcomaSSA summary ↗
- Leptomeningeal CarcinomatosisSSA summary ↗
- Lesch-Nyhan Syndrome (LNS)SSA summary ↗
- Lewy Body DementiaSSA summary ↗
- Liposarcoma – Metastatic or RecurrentSSA summary ↗
- LissencephalySSA summary ↗
- LMNA-Related Congenital Muscular DystrophySSA summary ↗
- Lowe SyndromeSSA summary ↗
- Lymphomatoid Granulomatosis – Grade IIISSA summary ↗
- Malignant Brain Stem Gliomas – ChildhoodSSA summary ↗
- Malignant EctomesenchymomaSSA summary ↗
- Malignant Gastrointestinal Stromal TumorSSA summary ↗
- Malignant Germ Cell TumorSSA summary ↗
- Malignant Migrating Partial Seizures of Infancy (MMPSI)New August 2026SSA summary ↗
- Malignant Multiple SclerosisSSA summary ↗
- Malignant Renal Rhabdoid TumorSSA summary ↗
- Mantle Cell Lymphoma (MCL)SSA summary ↗
- Maple Syrup Urine DiseaseSSA summary ↗
- Marshall-Smith SyndromeSSA summary ↗
- Mastocytosis – Type IVSSA summary ↗
- MECP2 Duplication SyndromeSSA summary ↗
- MedulloblastomaSSA summary ↗
- Megacystis Microcolon Intestinal Hypoperistalsis SyndromeSSA summary ↗
- Megalencephaly Capillary Malformation SyndromeSSA summary ↗
- Menkes Disease – Classic or Infantile Onset FormSSA summary ↗
- Merkel Cell Carcinoma – with MetastasesSSA summary ↗
- Merosin Deficient Congenital Muscular DystrophySSA summary ↗
- Metachromatic Leukodystrophy (MLD) – Late InfantileSSA summary ↗
- Metastatic Endometrial AdenocarcinomaSSA summary ↗
- Microvillus Inclusion Disease – ChildSSA summary ↗
- Mitral Valve AtresiaSSA summary ↗
- Mixed DementiasSSA summary ↗
- Mowat-Wilson SyndromeSSA summary ↗
- MPS I, formerly known as Hurler SyndromeSSA summary ↗
- MPS II, formerly known as Hunter SyndromeSSA summary ↗
- MPS III, formerly known as Sanfilippo SyndromeSSA summary ↗
- Mucosal Malignant MelanomaSSA summary ↗
- Multicentric Castleman DiseaseSSA summary ↗
- Multiple System AtrophySSA summary ↗
- Myelodysplastic Syndrome with Excess BlastsSSA summary ↗
- Myoclonic Epilepsy with Ragged Red Fibers SyndromeSSA summary ↗
- Neonatal AdrenoleukodystrophySSA summary ↗
- Neonatal Marfan SyndromeSSA summary ↗
- Nephrogenic Systemic FibrosisSSA summary ↗
- Neurodegeneration with Brain Iron Accumulation – Types 1 and 2SSA summary ↗
- NFU-1 Mitochondrial DiseaseSSA summary ↗
- Nicolaides-Baraister SyndromeSSA summary ↗
- Niemann-Pick Disease (NPD) – Type ASSA summary ↗
- Niemann-Pick Disease-Type CSSA summary ↗
- Non-Small Cell Lung CancerSSA summary ↗
- Nonketotic HyperglycinemiaSSA summary ↗
- NUT CarcinomaSSA summary ↗
- Obliterative BronchiolitisSSA summary ↗
- Ohtahara SyndromeSSA summary ↗
- Oligodendroglioma Brain Cancer – Grade IIISSA summary ↗
- OPHN1 SyndromeNew August 2026SSA summary ↗
- Ornithine Transcarbamylase (OTC) DeficiencySSA summary ↗
- Orthochromatic Leukodystrophy with Pigmented GliaSSA summary ↗
- Osteogenesis Imperfecta (OI) – Type IISSA summary ↗
- Osteosarcoma, formerly known as Bone CancerSSA summary ↗
- Ovarian Cancer – with Distant Metastases or Inoperable or UnresectableSSA summary ↗
- PACS1 SyndromeSSA summary ↗
- Pallister-Killian SyndromeSSA summary ↗
- Pancreatic CancerSSA summary ↗
- Paraneoplastic Cerebellar DegenerationSSA summary ↗
- Paraneoplastic PemphigusSSA summary ↗
- Patau Syndrome (Trisomy 13)SSA summary ↗
- Pearson SyndromeSSA summary ↗
- Pelizaeus-Merzbacher Disease-Classic FormSSA summary ↗
- Pelizaeus-Merzbacher Disease-Connatal FormSSA summary ↗
- Pericardial MesotheliomaSSA summary ↗
- Peripheral Nerve Cancer – Metastatic or RecurrentSSA summary ↗
- Peritoneal MesotheliomaSSA summary ↗
- Peritoneal Mucinous CarcinomatosisSSA summary ↗
- Perry SyndromeSSA summary ↗
- Pfeiffer Syndrome – Types II and IIISSA summary ↗
- Phelan-McDermid SyndromeSSA summary ↗
- Pineoblastoma – ChildhoodSSA summary ↗
- Pitt Hopkins SyndromeSSA summary ↗
- Plasmablastic LymphomaSSA summary ↗
- Pleural MesotheliomaSSA summary ↗
- Pompe Disease – InfantileSSA summary ↗
- Pontocerebellar HypoplasiaSSA summary ↗
- Posterior Cortical AtrophySSA summary ↗
- Primary Cardiac SarcomaNew August 2026SSA summary ↗
- Primary Central Nervous System LymphomaSSA summary ↗
- Primary Effusion LymphomaSSA summary ↗
- Primary Intracranial Malignant MelanomaNew August 2026SSA summary ↗
- Primary Omental CancerSSA summary ↗
- Primary Peritoneal CancerSSA summary ↗
- Primary Progressive AphasiaSSA summary ↗
- Progressive Bulbar PalsySSA summary ↗
- Progressive Multifocal LeukoencephalopathySSA summary ↗
- Progressive Muscular AtrophySSA summary ↗
- Progressive Supranuclear PalsySSA summary ↗
- Prostate Cancer – Hormone Refractory Disease – or with Visceral MetastasesSSA summary ↗
- Pulmonary Amyloidosis – AL TypeSSA summary ↗
- Pulmonary AtresiaSSA summary ↗
- Pulmonary Kaposi SarcomaSSA summary ↗
- Rasmussen EncephalitisSSA summary ↗
- Refractory Hodgkin LymphomaSSA summary ↗
- Renal Amyloidosis – AL TypeSSA summary ↗
- Renal Medullary CarcinomaSSA summary ↗
- Renpenning SyndromeSSA summary ↗
- Retinopathy of Prematurity – Stage V, BilateralSSA summary ↗
- Rett (RTT) SyndromeSSA summary ↗
- Revesz SyndromeSSA summary ↗
- RhabdomyosarcomaSSA summary ↗
- Rhizomelic Chondrodysplasia PunctataSSA summary ↗
- Richter SyndromeSSA summary ↗
- Roberts SyndromeSSA summary ↗
- Rubinstein-Taybi SyndromeSSA summary ↗
- Salivary CancersSSA summary ↗
- Sandhoff DiseaseSSA summary ↗
- Sarcomatoid Carcinoma of the Lung – Stages II – IVSSA summary ↗
- Sarcomatoid MesotheliomaSSA summary ↗
- Schindler Disease – Type 1SSA summary ↗
- SCN8A Related Epilepsy with EncephalopathySSA summary ↗
- Seckel SyndromeSSA summary ↗
- Secondary Adenocarcinoma of the BrainSSA summary ↗
- Severe Combined Immunodeficiency – ChildhoodSSA summary ↗
- Single VentricleSSA summary ↗
- Sinonasal CancerSSA summary ↗
- Sjogren-Larsson SyndromeSSA summary ↗
- Skin Malignant Melanoma with MetastasesSSA summary ↗
- Small Cell Cancer Large IntestineSSA summary ↗
- Small Cell Cancer of the Female Genital TractSSA summary ↗
- Small Cell Lung CancerSSA summary ↗
- Small Intestine Cancer – with Distant Metastases or Inoperable, Unresectable or RecurrentSSA summary ↗
- Smith Lemli Opitz SyndromeSSA summary ↗
- Snijders Blok-Campeau SyndromeSSA summary ↗
- Soft Tissue Sarcoma – with Distant Metastases or RecurrentSSA summary ↗
- Spinal Muscular Atrophy (SMA) – Types 0 and 1SSA summary ↗
- Spinal Nerve Root Cancer – Metastatic or RecurrentSSA summary ↗
- Spinocerebellar AtaxiaSSA summary ↗
- Stiff Person SyndromeSSA summary ↗
- Stomach Cancer – with Distant Metastases or Inoperable, Unresectable or RecurrentSSA summary ↗
- Subacute Sclerosing PanencephalitisSSA summary ↗
- Superficial Siderosis of the Central Nervous SystemSSA summary ↗
- SYNGAP1 – Related NSIDSSA summary ↗
- Tabes DorsalisSSA summary ↗
- Tay Sachs Disease – Infantile TypeSSA summary ↗
- Taybi-Linder SyndromeSSA summary ↗
- Tetrasomy 18pSSA summary ↗
- Thanatophoric Dysplasia – Type 1SSA summary ↗
- Thymic CarcinomaSSA summary ↗
- Thyroid CancerSSA summary ↗
- Transplant Coronary Artery VasculopathySSA summary ↗
- Tricuspid AtresiaSSA summary ↗
- Trisomy 9SSA summary ↗
- Turnpenny Fry SyndromeSSA summary ↗
- Ullrich Congenital Muscular DystrophySSA summary ↗
- Ureter Cancer – with Distant Metastases or Inoperable, Unresectable or RecurrentSSA summary ↗
- Usher Syndrome – Type ISSA summary ↗
- Uveal Melanoma – with MetastasesNew August 2026SSA summary ↗
- Ventricular Assist Device Recipient – Left, Right, or BiventricularSSA summary ↗
- Walker Warburg SyndromeSSA summary ↗
- Warburg Micro SyndromeNew August 2026SSA summary ↗
- WHO Grade III MeningiomasSSA summary ↗
- Wolf-Hirschhorn SyndromeSSA summary ↗
- Wolman DiseaseSSA summary ↗
- X-Linked Lymphoproliferative DiseaseSSA summary ↗
- X-Linked Myotubular MyopathySSA summary ↗
- Xeroderma PigmentosumSSA summary ↗
- Young-Onset Alzheimer's DiseaseSSA summary ↗
- Zellweger SyndromeSSA summary ↗
- Zhu-Tokita-Takenouchi-Kim SyndromeSSA summary ↗
How a claim is flagged
You do not file a special application. When you apply for disability, Social Security’s selection software reads the conditions you list on the disability report and flags the claim if one matches a condition on the list by name, synonym or abbreviation. That makes the exact wording matter. Write the diagnosis the way your doctor and records state it, such as “glioblastoma” or “metastatic breast cancer,” not only a symptom such as “headaches” or “a lump.” If you have cancer, include the type and the stage, because many cancers qualify only when they have spread, recurred or cannot be removed.
A claim can also be flagged by hand. If the diagnosis is made after you apply, or the software misses it, tell Social Security; staff can add the compassionate allowance designation at the initial level, at reconsideration, at a hearing or at the Appeals Council. The fast track does not apply to continuing disability reviews of people already receiving benefits.
What evidence is needed
Each condition has a summary in Social Security’s operations manual listing alternate names, how it is diagnosed and the medical evidence an examiner should look for. The search tool above links every condition to that summary, and it also finds conditions by their other names, so a search for “Lou Gehrig” finds ALS. For many conditions the requirement is short. For pancreatic cancer, for example, the manual says a pathology report showing the cancer is the only evidence needed to decide the claim. For others it may be a genetic test, an imaging study or a specialist’s diagnosis.
The flag only works if that evidence reaches the examiner. Give Social Security the names and addresses of every treating doctor and hospital, and if you have the pathology report, biopsy result or test that confirms the diagnosis, mention it. Social Security increasingly receives records electronically from health systems, but not in every case.
What the fast track does not change
The non-medical rules still apply in full. For SSDI you need enough recent work credits, and your disability must have begun on or before your date last insured. For SSI, your income and savings must be within the limits. Many people approved quickly on the medical side then wait while the field office finishes this review, and a claim that fails it is denied for non-medical reasons regardless of the diagnosis.
The five-month SSDI waiting period also applies. It is counted from the month your disability began, not from the approval, so someone whose disability began well before applying may have already served it. People with ALS are the exception and have no waiting period.
Watch out: Being on the list does not guarantee approval. Claims are denied when the records do not confirm the diagnosis or the required stage, or when the work or income rules are not met. If that happens, appeal within 60 days and send the missing evidence; the compassionate allowance designation can be added again on appeal.
How fast decisions are
Social Security does not publish a set timeline for compassionate allowance decisions. People in condition support groups often report medical approvals within a few weeks to about a month, compared with many months for typical claims, but the overall wait also depends on how quickly records arrive and how long the non-medical review takes. Payments then follow the usual schedule: SSDI is paid starting the sixth full month after onset, and SSI from the month after you apply.
If you are applying for SSI and your condition is clearly severe, Social Security can also pay up to six months of SSI before the final decision under presumptive disability, without repayment if the claim is later denied on medical grounds.
If your condition is not on the list
Other fast tracks may still apply. Social Security treats a claim as a terminal illness case when records show a condition that is untreatable and expected to result in death, including any cancer that has spread, is stage IV, has come back after treatment or cannot be removed, and people receiving hospice care or awaiting certain organ transplants. Those claims are expedited at every step. A computer model also picks out other claims likely to be approved quickly at the first level.
Most people who qualify are not on any list at all. The conditions that most often qualify are approved by meeting a listing in the Blue Book or through the full medical and vocational review of the five-step disability process. Anyone can also ask Social Security to consider adding a condition through the compassionate allowances website, and the application is the same either way.
The 14 conditions added in August 2026
Social Security added these conditions on August 11, 2026: Adenylosuccinate Lyase Deficiency (neonatal form and type 1), Aicardi Syndrome, Baraitser-Winter Syndrome, Beare-Stevenson Cutis Gyrata Syndrome, Bohring-Opitz Syndrome, CASK-Related Gene Disorders, Hepatosplenic T-Cell Lymphoma, Lafora Disease, Malignant Migrating Partial Seizures of Infancy, OPHN1 Syndrome, Primary Cardiac Sarcoma, Primary Intracranial Malignant Melanoma, Uveal Melanoma with metastases, and Warburg Micro Syndrome. They are marked “New Aug 2026” in the search tool above.